Gastroprotection in Low-Dose Aspirin Users for Primary and Secondary Prevention of ACS: Results of a Cost-Effectiveness Analysis Including Compliance von de Groot, N. L., van Haalen, H. G. M., Spiegel, B. M. R., Laine, L., Lanas, A., Focks, J. Jaspers, Siersema, P. D., van Oijen, M. G. H.

Volltext

Chemotherapy for ovarian cancer in the Netherlands: a population-based study on treatment patterns and outcomes von Houben, E., van Haalen, H. G. M., Sparreboom, W., Overbeek, J. A., Ezendam, N. P. M., Pijnenborg, J. M. A., Severens, J. L., van Herk-Sukel, M. P. P.

Volltext

Gastroprotective Strategies in Chronic NSAID Users: A Cost-Effectiveness Analysis Comparing Single-Tablet Formulations with Individual Components von de Groot, N.L., MD, Spiegel, B.M.R., MD, MSHS, van Haalen, H.G.M, MSc, de Wit, N.J., MD, PhD, Siersema, P.D., MD, PhD, van Oijen, M.G.H., PhD

Volltext

How to Select the Right Cost-Effectiveness Model?: A Systematic Review and Stepwise Approach for Selecting a Transferable Health Economic Evaluation Model for Rheumatoid Arthritis von van Haalen, H. G. M., Severens, J. L., Tran-Duy, A., Boonen, A.

Volltext

How to Select the Right Cost-Effectiveness Model? von van Haalen, H. G. M, Severens, J. L, Tran-Duy, A, Boonen, A

Volltext

Treatment Patterns And Outcomes Of Patients Diagnosed With Ovarian Cancer In The Netherlands: A Registry Study von Houben, E, van Haalen, H.G.M, Sparreboom, W, Overbeek, J.A, Ezendam, N, Pijnenborg, H, van Herk-Sukel, M.P.P

Volltext

Cost-Effectiveness of Ticagrelor 60 Mg in High-Risk Post-Mi Patients From A Dutch Societal Perspective von Moore, P, Briggs, A, Davies, A, Sculpher, M, Williams, J, Fenwick, E, van de Wetering, G, Magnuson, EA, Cohen, DJ, van Haalen, HG, Mellstrom, C

Volltext

PCV103 - Cost-Effectiveness of Ticagrelor 60 Mg in High-Risk Post-Mi Patients From A Dutch Societal Perspective von Moore, P, Briggs, A, Davies, A, Sculpher, M, Williams, J, Fenwick, E, van de Wetering, G, Magnuson, EA, Cohen, DJ, van Haalen, HG, Mellstrom, C

Volltext